RESEARCH MONOGRAPH · KDC-MN-114

Eleuthero (Eleutherococcus senticosus)

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

63/100

Soviet-era adaptogen with real history but thinner modern trial base than Panax

Eleuthero (or "Siberian ginseng," a marketing name, the plant is not a true Panax) is the adaptogen that got most of its modern research push in the Soviet Union from the 1960s onward. Brekhman and Dardymov essentially coined the modern "adaptogen" framework around eleuthero, working on Soviet military and cosmonaut performance applications. A lot of the early literature is in Russian and never properly translated, which is part of why the Western trial base looks thinner than it actually is.

The active chemistry is the eleutherosides, a structurally heterogeneous family including phenylpropanoids, lignans, and triterpene saponins. The naming is confusing because the "eleutherosides" are not all chemically related, theyre just compounds isolated from this plant. Eleutheroside B (syringin) and eleutheroside E (syringaresinol diglucoside) are the two most-studied marker compounds, but neither is clearly the principal pharmacological actor.

Mechanistically the literature is much less mature than for Panax. There's plausible HPA axis modulation, some immune-cell activity, modest cognitive endpoint signals in small trials, and some endurance-performance signals at moderate-to-high doses. The Wagner 1985 work on physical performance enhancement in trained subjects was foundational but has not been thoroughly replicated at modern standards.

What we like: long historical use including the Soviet performance-and-stress research, plausible biology, reasonable safety profile, low cost. The molecule itself is more chemically diverse than people give it credit for.

What we dont like is the modern trial gap. There isn't a strong recent RCT base, the extracts vary wildly in standardization, and most commercial products use eleutheroside B+E content as the marker even though those compounds aren't clearly the dominant actives. Adulteration with Periploca sepium (a different plant that was sometimes substituted in older Chinese supply chains) used to be a real problem and may still be in cheap material.

Sourcing: look for material standardized to eleutherosides B+E content (the EGb 761 and similar commercial extracts have published standardizations, though eleuthero is not as commercialized as Panax). Pure syringin or eleutheroside E for research mechanism work is available at high purity. Avoid unstandardized "Siberian ginseng" without analytical backing, the variance is real.

Honestly, less well-supported than Panax in modern trials but with an interesting historical research base. Worth knowing about, the marketing claims often outrun the data.

Evidence: 50
Mechanism: 55
Reliability: 55
Safety: 82
Sourcing: 65
Value: 75
Signal: 58
Staying power: 60

Plain-language summary Intrigue 52 / 100

Eleuthero (Siberian ginseng, Eleutherococcus senticosus) is unrelated to true ginseng but shares similar adaptogenic properties. Eleutherosides drive the activity. Used historically by Soviet athletes and astronauts. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Siberian ginseng adaptogen

A Siberian Eleutherococcus root extract historically classified as 'ginseng' but unrelated to Panax; characterized by eleutherosides with adaptogenic activity.

Abstract

Eleuthero (Eleutherococcus senticosus, formerly called Siberian ginseng) is a shrub root used in Russian and Chinese traditional medicine for fatigue, stress tolerance, and immune support. The active constituents are eleutherosides A through G, glycoside compounds with diverse structures (some are syringaresinol diglucosides, others are sesamin glucosides). The compound is structurally and pharmacologically distinct from Panax ginseng despite the historical "ginseng" naming. Russian research from the 1960s-1980s established the compound as an adaptogen with modest effects on physical and mental performance. The Western clinical evidence base is limited. Reported research dose ranges in the literature use standardized extract.

Mechanism of action

Eleutheroside glycoside constituents with adaptogenic effects. Modulation of HPA axis under stress conditions.

Reported research dose ranges

Reported research dose ranges in the literature describe standardized extract quantities.

References

Panossian A, Wikman G. Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. J Ethnopharmacol 2008 (related literature).

Read the full monograph

The full reference document covers compound identification, discovery and developmental history, mechanism of action, pharmacokinetics, reported research dose ranges, sourcing and quality verification, reconstitution and handling, stack interaction considerations, and a curated reference list. Available as a research-use-only PDF download.

KDC-MN-114

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Eleuthero (Eleutherococcus senticosus)

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs